My Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.

Press releases published on August 31, 2026

Aug. 31, 2026

Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day

Indeterminate GlobeNewswire

Aug. 31, 2026

NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 31, 2026

SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers

Indeterminate GlobeNewswire

Aug. 31, 2026

Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire

Aug. 31, 2026

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

Indeterminate GlobeNewswire

Aug. 31, 2026

Ascendis and BioMarin Enter Binding Term Sheet for a Global Settlement and License Agreement Related to YUVIWEL® (Navepegritide)

Indeterminate GlobeNewswire

Aug. 31, 2026

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

Indeterminate GlobeNewswire

Aug. 31, 2026

Global Markets for Fermentation Ingredients to Reach $53.4 Billion by 2031, Driven by Rising Demand for Animal Nutrition Ingredients

Indeterminate GlobeNewswire

Aug. 31, 2026

Global Markets and Technologies for Electronic Health Records to Reach $52.2 Billion by 2030, Driven by Rising Chronic Disease Burden and Digital Health Adoption

Indeterminate GlobeNewswire

Aug. 31, 2026

Medera Presents Late-Breaking Clinical Trial Data at ESC Congress 2026 Demonstrating Durable Improvement in HFpEF Cardiac Filling Pressures Following SRD-002 Gene Therapy

Indeterminate GlobeNewswire

Aug. 31, 2026

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

Indeterminate GlobeNewswire

Aug. 31, 2026

XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation

Indeterminate GlobeNewswire

Aug. 31, 2026

AI Disruption in Electronic Health Records Accelerates as Venture Capital Inflows Surpass $1 Billion in 2025

Indeterminate GlobeNewswire

Aug. 31, 2026

Leios Therapeutics Announces Exclusive Licensing Agreement and Strategic Investment with Subsidiaries of China Medical System Holdings Ltd. for 10XB-101

Indeterminate GlobeNewswire

Aug. 31, 2026

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China

Indeterminate GlobeNewswire